AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Creative Medical Technology Holdings, Inc. Common Stock
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG001S924N1
0.74▼ 0.03 (-4.39%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
—
Trading Information
Previous Close
0.77
Day's Range
0.73 – 0.77
52-Week Range
0.62 – 6.25
Volume
24.5K
Avg Volume
447.7K
Share Statistics
Shares Outstanding
Employees
4
Exchange
XNAS
Listed
2009-04-30
Share count as of August 7, 2026

Creative Medical Technology Holdings, Inc. Common Stock (CELZ) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Creative Medical Technology Holdings, Inc. Common Stock (CELZ)
What is Creative Medical Technology Holdings, Inc. Common Stock's Market Cap?
Creative Medical Technology Holdings, Inc. Common Stock's Market Cap is $4.9M, based on as-reported figures from SEC (XBRL) filings.
What is Creative Medical Technology Holdings, Inc. Common Stock's Price / Sales?
Creative Medical Technology Holdings, Inc. Common Stock's Price / Sales is 1626.2×, based on as-reported figures from SEC (XBRL) filings.
What is Creative Medical Technology Holdings, Inc. Common Stock's Revenue (TTM)?
Creative Medical Technology Holdings, Inc. Common Stock's Revenue (TTM) is $3.0K, based on as-reported figures from SEC (XBRL) filings.
What is Creative Medical Technology Holdings, Inc. Common Stock's Net Income (TTM)?
Creative Medical Technology Holdings, Inc. Common Stock's Net Income (TTM) is -$6.0M, based on as-reported figures from SEC (XBRL) filings.
What is Creative Medical Technology Holdings, Inc. Common Stock's EBITDA?
Creative Medical Technology Holdings, Inc. Common Stock's EBITDA is -$6.1M, based on as-reported figures from SEC (XBRL) filings.
What is Creative Medical Technology Holdings, Inc. Common Stock's Diluted EPS (TTM)?
Creative Medical Technology Holdings, Inc. Common Stock's Diluted EPS (TTM) is -0.92, based on as-reported figures from SEC (XBRL) filings.
What is Creative Medical Technology Holdings, Inc. Common Stock's EBITDA Margin?
Creative Medical Technology Holdings, Inc. Common Stock's EBITDA Margin is -204211.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · CELZAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue
YoY growth—-100.0%+0.0%—
Cost of Revenue
Gross profit
% of revenue——66.9%—
OPERATING EXPENSES
Research and Development Expense
Selling, General and Administrative Expense
Amortization
TOTAL EXPENSES
% of revenue——64926.3%—
Operating loss
% of revenue——-64859.4%—
OTHER INCOME/(EXPENSE)
Interest Income
Total other income (expense)
LOSS BEFORE PROVISION FOR INCOME TAXES
Income Tax Expense
NET LOSS
% of revenue——-62922.5%—
Net Income Attributable to Noncontrolling Interest——
NET LOSS ATTRIBUTABLE TO CMTH——
% of revenue————
Earnings Per Share (Diluted)